FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

OIG Work Plan Has 5 Drug, Device Activities

[ Price : $8.95]

The HHS Inspector General releases a 2017 work plan with five items relating to FDA oversight of drugs and medical devices.

Virtus Pharmaceuticals Petition Denied on Procedural Grounds

[ Price : $8.95]

FDA denies on procedural grounds a Virtus Pharmaceutical petition asking it to investigate whether two producers of potassium chlo...

Americans Oppose Off-label Promotion: Consumer Reports

[ Price : $8.95]

Consumer Reports shares with FDA results from a new poll showing that most Americans (84%) do not want companies to be allowed to ...

21st Century Cures Bill a Disaster Still: Yale Critic

[ Price : $8.95]

Yale Universitys Collaboration for Research Integrity and Transparency renews its sharp criticism of the pending 21st Century Cure...

Senate and House Leaders Eager to Push Cures Act Through

[ Price : $8.95]

Senate and House leaders signal strong interest in seeing the 21st Century Cures Act signed into law this year.

Comments Sought on Radiation Product Requirements

[ Price : $8.95]

Federal Register Notice: FDA seeks comments on an OMB submission to extend an information collection on reporting and recordkeepin...

Draft Guide on Surgical Aspirator Device Labeling

[ Price : $8.95]

Federal Register Notice: FDA makes available a draft guidance on Product Labeling for Certain Ultrasonic Surgical Aspirator Device...

Partial Clinical Hold Lifted on Adaptimmune T-cell Therapy

[ Price : $8.95]

FDA removes a partial clinical hold on a Adaptimmune Therapeutics planned study of its NY‑ESO SPEAR (Specific Peptide Enhanc...

Multiple Violations at Cantrell Drug Company

[ Price : $8.95]

FDA publishes an FDA-483 with 12 inspection observations from Cantrell Drug Co., an outsourcing facility.

FDA Starts Neurological Device Web Site

[ Price : $8.95]

FDA launches a new Web site to help sponsors and innovators of neurological medical devices.